Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 1/6 |
Zhejiang Garden Biopharmaceutical Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥11.41 |
52 Week High | CN¥12.71 |
52 Week Low | CN¥7.58 |
Beta | -0.049 |
1 Month Change | 14.56% |
3 Month Change | 24.97% |
1 Year Change | -9.87% |
3 Year Change | -15.54% |
5 Year Change | -17.38% |
Change since IPO | 465.41% |
Recent News & Updates
Shareholder Returns
300401 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | 5.1% | 5.7% | 4.2% |
1Y | -9.9% | -11.0% | -13.2% |
Return vs Industry: 300401 exceeded the CN Pharmaceuticals industry which returned -11% over the past year.
Return vs Market: 300401 exceeded the CN Market which returned -13.2% over the past year.
Price Volatility
300401 volatility | |
---|---|
300401 Average Weekly Movement | 6.7% |
Pharmaceuticals Industry Average Movement | 7.7% |
Market Average Movement | 8.7% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 300401's share price has been volatile over the past 3 months.
Volatility Over Time: 300401's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | 943 | Huanzheng Ma | www.hybiotech.com |
Zhejiang Garden Biopharmaceutical Co.,Ltd. manufactures and supplies lanolin cholesterol, vitamin D3, 25-hydroxyvitamin D3, and refined lanolin products in China. It offers cholesterol; feed grade cholesterol; food additives compound nutrient fortifier SDS, CO, and MO; cholecalciferol; feed additive - vitamin D3 particles and oil; VD3 resin oil; 25 hydroxyvitamin D3 progen and powder; 25 hydroxyvitamin D3; anhydrous lanolin; wood oil; wool wax; low chroma pure fat; lanolin alcohol; isopropyl lanolate; lanolinic acid; high acid fat; wood acid biofuel/wood alcohol biofuel; and rodenticide made from Vitamin D3.
Zhejiang Garden Biopharmaceutical Co.,Ltd. Fundamentals Summary
300401 fundamental statistics | |
---|---|
Market cap | CN¥6.16b |
Earnings (TTM) | CN¥231.97m |
Revenue (TTM) | CN¥1.11b |
26.6x
P/E Ratio5.6x
P/S RatioIs 300401 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300401 income statement (TTM) | |
---|---|
Revenue | CN¥1.11b |
Cost of Revenue | CN¥456.75m |
Gross Profit | CN¥651.05m |
Other Expenses | CN¥419.08m |
Earnings | CN¥231.97m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.43 |
Gross Margin | 58.77% |
Net Profit Margin | 20.94% |
Debt/Equity Ratio | 52.4% |
How did 300401 perform over the long term?
See historical performance and comparison